• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Results of percutaneous transluminal angioplasty].

作者信息

Zeitler E, Feng G, Oldendorf M, Richter E I, Ritter W, Seyferth W

机构信息

Radiologisches Zentrum des Städtischen Klinikums Nürnberg, Abteilung Diagnostik.

出版信息

Herz. 1989 Feb;14(1):22-8.

PMID:2522077
Abstract

Percutaneous transluminal angioplasty (PTA) can be subdivided into three epochs: 1. from its inception by Dotter and Judkins up to the first coronary artery stenosis dilatation with the Grüntzig balloon catheter system; 2. from the introduction of coronary stenosis dilatation by Grüntzig up to its unequivocal acceptance; 3. the period of influence of low-risk coronary dilatation on peripheral angioplasty and the search for techniques to compliment or obviate the need for balloon dilatation. The Grüntzig double-lumen balloon catheter system contributed to the lower rate of complications and higher success rate. The clinical acceptance appeared greater for the coronary arteries since, in contrast to the peripheral vascular system, the indication for treatment is established by the physician performing the dilatation. PTA implies percutaneous puncture of a vessel with Seldinger technique and introduction of devices such as guidewires, Dotter or Grüntzig catheters among others, catheters with fiberglass for laser conduction and instruments for fractionating, drilling and cutting. The goal of PTA is to completely or partially eliminate, without surgery, intraluminal vascular narrowing in the presence of peripheral arterial disease in stage II, III or IV. Prerequisite to the use of PTA are: 1. adequate fluoroscopic and angiographic facilities; 2. adequate instrumentation; 3. experience with at least 200 procedures; 4. knowledge of the pathophysiology and adjunctive treatment; 5. knowledge of the treatment of complications; 6. cooperation with a vascular surgery service. A number of factors may influence the results of treatment. Adjunctive medical treatment: the use of platelet aggregation inhibitors and heparin influences the rate of early rethrombosis.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
[Results of percutaneous transluminal angioplasty].
Herz. 1989 Feb;14(1):22-8.
2
[Operation and angioplasty in peripheral arterial occlusive disease].[外周动脉闭塞性疾病的手术与血管成形术]
Z Kardiol. 1993;82 Suppl 5:111-8.
3
[Percutaneous peripheral laser angioplasty: initial clinical results].经皮外周激光血管成形术:初步临床结果
Z Kardiol. 1988 Jan;77(1):29-35.
4
Primary and late results of percutaneous transluminal angioplasty (PTA) in iliac and femoro-popliteal obliterations.
Int Angiol. 1985 Jan-Mar;4(1):81-5.
5
[Percutaneous transluminal angioplasty (PTA) in peripheral arterial occlusive disease of the lower extremities].[下肢周围动脉闭塞性疾病的经皮腔内血管成形术(PTA)]
Wien Klin Wochenschr. 1986 Jan 24;98(2):33-40.
6
[Percutaneous transluminal angioplasty in subclavian artery stenosis].
No Shinkei Geka. 1986 Aug;14(9):1127-32.
7
[Percutaneous transluminal laser angioplasty in peripheral arterial occlusive disease--development of a new laser catheter system].[经皮腔内激光血管成形术治疗周围动脉闭塞性疾病——一种新型激光导管系统的研发]
Z Kardiol. 1988 Apr;77(4):245-50.
8
[Percutaneous transluminal angioplasty. Non-surgical treatment of vascular stenoses and occlusions with balloon catheters (author's transl)].
Nouv Presse Med. 1981 Jun 13;10(26):2197-201.
9
Percutaneous transluminal coronary angioplasty.
Tokai J Exp Clin Med. 1986 May;11(2):71-86.
10
[Conservative therapy of arterial occlusive disease].[动脉闭塞性疾病的保守治疗]
Herz. 1989 Feb;14(1):1-11.